Autoschizis

From WikiMD's WELLNESSPEDIA

Autoschizis is a form of cell death that is characterized by the loss of cytoplasmic content through self-excision. This process is distinct from other forms of cell death such as apoptosis and necrosis in that it does not involve the breakdown of the cell's nuclear material. Instead, the cell's cytoplasmic content is lost through a process of self-excision, leading to the formation of a residual body that is eventually phagocytosed by neighboring cells.

Mechanism[edit]

The exact mechanism of autoschizis is not fully understood. However, it is believed to involve a series of steps that lead to the loss of cytoplasmic content. First, the cell undergoes a process of self-excision, in which parts of the cytoplasm are cut away. This is followed by the formation of a residual body, which is a small, dense structure that remains after the loss of cytoplasmic content. Finally, the residual body is phagocytosed by neighboring cells, effectively removing the cell from the tissue.

Role in Disease[edit]

Autoschizis has been observed in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. In cancer, autoschizis may play a role in the death of tumor cells, potentially contributing to the effectiveness of certain chemotherapy drugs. In neurodegenerative diseases, autoschizis may contribute to the loss of neurons, leading to the symptoms of these diseases. In autoimmune diseases, autoschizis may play a role in the death of immune cells, potentially contributing to the progression of these diseases.

Research[edit]

Research into autoschizis is ongoing, with scientists seeking to better understand the mechanism of this form of cell death and its role in disease. This research could potentially lead to new treatments for diseases in which autoschizis plays a role.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.